SKYE Deadline: Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders to Contact the Firm for Information About Their Rights

Core Viewpoint - Rosen Law Firm is investigating allegations that Skye Bioscience, Inc. misled investors regarding its business operations during the specified period [1] Group 1: Company Overview - Skye Bioscience, Inc. is identified as a clinical stage biopharmaceutical company [1] Group 2: Legal Investigation - The investigation pertains to securities purchased between November 4, 2024, and October 3, 2025 [1] - Investors are reminded to submit a form, email attorney Phillip Kim, or call for more information regarding the allegations [1]